The National Institute of Allergy and Infectious Diseases (NIAID) intends to procure Expi293™ Expression Medium, Quantity: 400 each, from Life Technologies Corporation, 3175 Staley Road, Grand Island, New York 14072.  Expi293™ Expression Medium is a chemically defined, serum-free, protein-free medium for growth and transfection of suspension-adapted human embryonic kidney (HEK) 293 cells. It is specifically designed as a core component to support high density culture of Expi293F™ cells in the Expi293™ Expression System for scalable transient protein expression. Any other similar product would result in changes to the existing experiment.

This will be a firm fixed price contract in accordance with the statutory authority for this sole source requirement 41 U.S.C. 253 (c) (1) as implemented by FAR 6.302-1 only one source available, no substitutions possible.  THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION; QUOTATIONS ARE NOT BEING REQUESTED, AND A WRITTEN SOLICITATION WILL NOT BE ISSUED.  The incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2005-78, dated November 25, 2014.  The associated North American Industry Classification System (NAICS) Code is 325414, which has a size standard of 500 employees.  All responsible sources who feel they can meet these requirements shall submit an offer that will be considered by the Agency.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.  Offers must be submitted no later than 5:00 P.M. Eastern Standard Time Wednesday, December 24, 2014 through the U.S. Postal Service at the address of NIH/NIAID/AMOB, 5601 Fishers Lane, Room 3A55, MSC 9822, Rockville, MD, 20852-9822.   Email and fax submissions are acceptable.  Point of contact concerning this requirement is Merle Dixon can be reached by phone and 240-669-5096, or e-mailed to [email protected].  Collect calls will not be accepted.